Early use of SGLT2 inhibitors after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
{{output}}
Introduction: Acute myocardial infarction (AMI) continues to be a primary cause of post-hospitalization heart failure (HF), severely impacting morbidity, healthcare resource consumption, and mortality rates. ... ...
